Difficulty: Medium
Average Score: 68%
Practice
Hereditary angioneurotic oedema (HANE):
Correct answer
A
Rationale
In the context of hereditary angioneurotic edema (HANE), the correct answer is A) Deficiency of C1 esterase occurs. This condition is characterized by a genetic deficiency or dysfunction of C1 esterase inhibitor, leading to uncontrolled activation of the complement system and bradykinin release, resulting in episodes of angioedema.
Option B) Can present as recurrent abdominal pain is incorrect because HANE typically presents with recurrent episodes of non-pitting edema affecting the skin and mucous membranes rather than abdominal pain.
Option C) C4 is increased is incorrect because in HANE, C4 levels are typically decreased due to uncontrolled complement activation and consumption.
Option D) Androgen agonists are helpful in management is incorrect because androgen agonists can exacerbate symptoms in HANE due to their potential to increase bradykinin levels.
Educationally, understanding the pathophysiology of HANE is crucial for nurses caring for pediatric patients as prompt recognition and management of angioedema episodes are essential to prevent life-threatening complications. Recognizing the genetic basis of HANE and the role of C1 esterase inhibitor deficiency in its pathogenesis can guide appropriate interventions and improve patient outcomes.
Option B) Can present as recurrent abdominal pain is incorrect because HANE typically presents with recurrent episodes of non-pitting edema affecting the skin and mucous membranes rather than abdominal pain.
Option C) C4 is increased is incorrect because in HANE, C4 levels are typically decreased due to uncontrolled complement activation and consumption.
Option D) Androgen agonists are helpful in management is incorrect because androgen agonists can exacerbate symptoms in HANE due to their potential to increase bradykinin levels.
Educationally, understanding the pathophysiology of HANE is crucial for nurses caring for pediatric patients as prompt recognition and management of angioedema episodes are essential to prevent life-threatening complications. Recognizing the genetic basis of HANE and the role of C1 esterase inhibitor deficiency in its pathogenesis can guide appropriate interventions and improve patient outcomes.